Virax Biolabs Group Ltd (NASDAQ:VRAX) currently has a daily average trading volume of 1.73M but it saw 3266126 shares traded in last market. With a market cap of 10.29M USD, the company’s current market price of $2.37 came rising about 39.41 while comparing to the previous closing price of $1.70. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.00 and as low as $0.60. In the recent trading on the day, stock has struck highest price mark of $1.6001 while lowest mark touched by it was $2.38.
Taking a look at 20-day trading activity of Virax Biolabs Group Ltd (VRAX) gives us an average price of $1.8600, while its current price level is -73.67% below from 52-week high level whereas it is 295.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.9200 while that of 200 days or SMA-200 reads an average of $1.6500. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.58% during that period while stretching the period over a month that decreases to 10.10%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.60 which implies that the stock is in neutral territory.
Over the week, VRAX’s stock price is moving 39.41% up while it is 26.06% when we observe its performance for the past one month. Year-to-date it is 62.33% up and over the past year, the stock is showing an upside performance of 69.29%.
Currently, Virax Biolabs Group Ltd’s total number of outstanding shares is 4.34M. Company’s return on investment (ROI) stands at -73.30% and return on equity (ROE) at -87.87%. Stock’s beta reads 1.85. Stock has a price to book (P/B) ratio of 0.71 while price to sale or P/S ratio amounts to 128.57. Its return on asset (ROA) is -79.92% on average.
